Maricela Arana Mendez1, Leslie Arguello1, Joaquin Martinez1, Marisela Salas Vargas2, Ana Maria Alvarado Rodriguez2, Carrie E Papa3, Carolyn M Peterseim3, Mauricio Otárola Víquez4, Rupal H Trivedi3, Mae Millicent W Peterseim5. 1. Department of Ophthalmology, National Children's Hospital of Costa Rica, San Jose, Costa Rica. 2. Clinica Ophthalmologica, San Jose, Costa Rica. 3. Miles Center for Pediatric Ophthalmology, Storm Eye Institute, Department of Ophthalmology, Medical University of South Carolina, Charleston, South Carolina. 4. Department of Pediatrics, Clinica Dr. Clorito Picado, San Jose, Costa Rica. 5. Miles Center for Pediatric Ophthalmology, Storm Eye Institute, Department of Ophthalmology, Medical University of South Carolina, Charleston, South Carolina. Electronic address: petersem@musc.edu.
Abstract
BACKGROUND: The Spot Vision Screener has demonstrated good sensitivity and specificity in the pediatric ophthalmology clinic setting. We sought to evaluate the updated Spot (version 2.0.16) in a general pediatric population through a collaboration of the Storm Eye Institute of the Medical University of South Carolina, the Clinica Dr Clorito Picado, and National Children's Hospital of Costa Rica. We compared results of screening with the Spot and pediatric ophthalmologic examination and determined sensitivity and specificity of the Spot in detecting amblyogenic risk factors (ARFs) according to the 2013 AAPOS Vision Screening Committee guidelines for automated vision screeners. METHODS: Children were screened with the Spot followed by a pediatric ophthalmologic examination. Cycloplegic refraction and motility findings were analyzed by age group to determine ARFs. RESULTS: A total of 219 subjects, averaging 60 months of age (range, 20-119 mo) were included. The prevalence of ARFs in our population was 12.3% (27/219). The most common risk factor was astigmatism, with a prevalence of 8.7% (19/219). The Spot referred 43 children (19.6%). Sensitivity of the Spot was 92.6%; specificity, 90.6%. The positive predictive value was 58.1%; the negative predictive value, 98.9%. CONCLUSIONS: The Spot demonstrated good sensitivity and specificity in detecting amblyopia risk factors in this general pediatric population.
BACKGROUND: The Spot Vision Screener has demonstrated good sensitivity and specificity in the pediatric ophthalmology clinic setting. We sought to evaluate the updated Spot (version 2.0.16) in a general pediatric population through a collaboration of the Storm Eye Institute of the Medical University of South Carolina, the Clinica Dr Clorito Picado, and National Children's Hospital of Costa Rica. We compared results of screening with the Spot and pediatric ophthalmologic examination and determined sensitivity and specificity of the Spot in detecting amblyogenic risk factors (ARFs) according to the 2013 AAPOS Vision Screening Committee guidelines for automated vision screeners. METHODS:Children were screened with the Spot followed by a pediatric ophthalmologic examination. Cycloplegic refraction and motility findings were analyzed by age group to determine ARFs. RESULTS: A total of 219 subjects, averaging 60 months of age (range, 20-119 mo) were included. The prevalence of ARFs in our population was 12.3% (27/219). The most common risk factor was astigmatism, with a prevalence of 8.7% (19/219). The Spot referred 43 children (19.6%). Sensitivity of the Spot was 92.6%; specificity, 90.6%. The positive predictive value was 58.1%; the negative predictive value, 98.9%. CONCLUSIONS: The Spot demonstrated good sensitivity and specificity in detecting amblyopia risk factors in this general pediatric population.
Authors: Chinwe Cynthia Jac-Okereke; Chukwunonso Azubuike Jac-Okereke; Ifeoma Regina Ezegwui; Obiekwe Okoye Journal: J Prim Care Community Health Date: 2020 Jan-Dec
Authors: Ziaul Haq Yasir; Fatimah Abdullah Basakran; Nora Ali Alhumaid; Malek Abdulrahman Balous; Abdulrahman Salem Banaeem; Ahmad Khaled Al-Shangiti; Rajiv Khandekar Journal: Oman J Ophthalmol Date: 2022-03-02